Makani Science is one step closer to commercial launch. The Irvine medtech company last month received 510(k) clearance from the Food and Drug Administration for its wireless, wearable respiratory monitor in adults. “It shows that our device not only works as we say it does, but it shows that it’s Read More
Forever Ageless Inc. is seeing continued growth for its aesthetics treatments and services. Since the Newport Beach medspa won a Business Journal Family-Owned Business Award in the medium-sized company category last May, business has grown about 9.8%, which is “great for our industry,” according to Zara Cerni. “We were still Read More
Newport Beach-based Positive Beverage LLC today announced that it has expanded to 18 Harvest Food stores. The beverage startup’s alternative energy drinks and sparkling waters will be sold in all Washington locations of the grocer, expanding its presence on the West Coast. “The heightened awareness and focus surrounding food and Read More
Headcount for Orange County’s public relations firms remained steady in 2025 as the industry adapted to changing technologies. The region’s 24 largest agencies reported a 1.3% increase in employees to 379 full-time staff, up from last year when it fell 2.7%, according to this week’s Business Journal list. Artificial intelligence Read More
Irvine-based medical device maker Masimo Corp. today announced that it has entered into an agreement to sell its Sound United consumer audio business to Harman International, a wholly owned subsidiary of Samsung Electronics Co., for $350 million. “Since I took over as CEO, a key objective has been refocusing our Read More
Hoag Memorial Hospital Presbyterian has appointed Dr. Jack Sun to lead the cardiovascular surgery program at Hoag’s Jeffrey M. Carlton Heart & Vascular Institute. “Dr. Sun’s arrival marks a new chapter for cardiac care at Hoag,” Hoag Chief Executive and President Robert Braithwaite said in a statement. The cardiovascular surgery Read More
CG Oncology Inc.’s latest research effort to treat bladder cancer is impressing investors. The Irvine-based biopharmaceutical company on April 26 reported a 75.5% remission rate in patients with high-risk non-muscle invasive bladder cancer in its Phase 3 BOND-003 clinical trial. Of the 110 patients, 51 maintained remission after one year Read More
Corstasis Therapeutics Inc. took inspiration from Narcan when coming up for its own nasal spray. “It got me thinking, ‘What could we potentially repurpose into a nasal spray for cardiology?’” Chief Executive Benjamin “Ben” Esque told the Business Journal. For five years, the clinical-stage pharmaceutical company has developed Enbumyst, a Read More
Edwards Lifesciences Corp. today announced that it received Food and Drug Administration approval for its Sapien 3 platform in asymptomatic patients with severe aortic stenosis. It marks the first approved transcatheter aortic valve replacement therapy in asymptomatic patients, according to the company. “There is an urgent need to change practice Read More
Hoag Memorial Hospital Presbyterian has named a renowned expert specializing in gastrointestinal cancer as the new executive medical director of its Hoag Family Cancer Institute. Dr. Steven Grossman’s appointment, announced April 28, comes amid Hoag’s $1.2 billion six-building expansion in Irvine. He replaces Dr. Burton Eisenberg, who is also Grace Read More
